FDA Guidance for Industry Postmarketing Safety Reporting for Human Drug and Biological Products Including Vaccines DRAFT GUIDANCE
Titel:
FDA Guidance for Industry
Postmarketing Safety Reporting
for Human Drug and Biological
Products Including Vaccines
DRAFT GUIDANCE
Internet:
Herkunft/Verlag:
Freedom of Information Staff, (HFI 35), Food and Drug Administration, Rm. 12 A - 30, 5600 Fishers Lane, Rockville, MD 20857, USA, http://www.fda.gov/
Dokumentenart:
Guidance for Industry DRAFT
Inhalt:
Sicherheits report nach der Markteinführung